Platform|API|Archive|Contact

Humanexa SignalsPharmaceutical Intelligence

FDA
EMA
MHRA
PMDA
Health Canada

Phase I
Phase II
Phase III
Readouts
Enrollment Signals

Pipeline Tracking
Company Moves
Asset Intelligence
Landscape Reports

Pricing
Access
Commercial
Launch Tracking

Licensing
Acquisitions
Partnerships
Capital Raises

Strategy Catalysts Pricing

Humanexa Signals

Data-driven pharmaceutical intelligence for biotech investors, pharma operators, consultants, and intelligence teams.

Powered by Humanexa

Categories

Regulatory
Clinical
Competitive
Markets
M&A Watch
Strategy
Catalyst Tracker

Company

Pricing
Partner with us
Subscribe
Contact
Privacy

Subscribe to Humanexa Signals

Weekly intelligence for pharma decision-makers.

No paywall. No spam. Unsubscribe anytime.

© 2026 Humanexa Signals. All rights reserved.

Intelligence powered by the Humanexa engine.

Therapeutic Area

Musculoskeletal

Therapeutic area intelligence for Musculoskeletal with 13 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals: 13
Catalysts: 0
Companies: 0

Companies

No related entities indexed yet.

Assets

glucosamine →

Musculoskeletal →

Recent signals(13)

ClinicalAugust 5, 2026

CBD Study Investigates Pain Relief for Knee Osteoarthritis

A clinical trial is underway to evaluate the efficacy of topically applied CBD for knee osteoarthritis pain relief.

ClinicalAugust 4, 2026

Study on Shock Wave Therapy for Lateral Epicondylitis Shows Potential Benefits

A randomized controlled study is evaluating the efficacy of extracorporeal shock wave therapy on trigger points in lateral epicondylitis patients.

ClinicalJuly 23, 2026

Study on Music Therapy's Effects in Chronic Neck Pain Rehabilitation

A study is investigating the effects of music therapy on pain and balance in chronic neck pain patients.

ClinicalJuly 23, 2026

Shock Wave Therapy Trial for Knee Osteoarthritis Shows Potential for Clinical Practice Change

A randomized controlled trial is assessing the efficacy of shockwave therapy combined with exercise for knee osteoarthritis.

ClinicalJuly 20, 2026

Local Corticosteroid Injection Shows Promise Over Surgery for De Quervain Tenosynovitis

A study comparing corticosteroid injections to surgical release in De Quervain tenosynovitis is underway, assessing pain outcomes.

ClinicalJuly 18, 2026

Pilot Trial on Culturally Tailored Exercise Program for Hispanics with Knee OA

A pilot randomized controlled trial is being conducted to evaluate a culturally acceptable treatment program for Hispanics with knee osteoarthritis.

CompetitiveJuly 15, 2026

Digital Rehabilitation Program for Knee Osteoarthritis Using AI and Wearable Technology

A clinical trial is underway to evaluate a digital rehabilitation program for knee osteoarthritis, integrating AI and wearable technology.

ClinicalJuly 12, 2026

Clinical Trial on Plant-derived CFA for Knee Pain Shows Promise for Joint Health

A clinical trial is underway to assess the efficacy and safety of plant-derived cetylated fatty acids (CFA) on knee pain and stiffness in adults.

ClinicalJuly 5, 2026

Clinical Trial Evaluates Intra-Articular Ozone for Knee Osteoarthritis

A clinical trial is assessing the efficacy of varying doses of intra-articular ozone injections in knee osteoarthritis patients aged 40-75.

CompetitiveJuly 1, 2026

ZetrOZ initiates trial for LITUS in knee osteoarthritis pain relief

ZetrOZ, Inc. is conducting a trial to evaluate the efficacy of long-duration low intensity therapeutic ultrasound for knee osteoarthritis pain relief.

ClinicalJune 25, 2026

Hydroxytyrosol-loaded hydrogel shows promise for cartilage regeneration in osteoarthritis

A genipin-crosslinked gelatin/PVA hydrogel effectively delivers Hydroxytyrosol, enhancing chondrocyte viability and metabolic activity.

ClinicalJune 24, 2026

Study on Ozone Injection Therapy for Knee Osteoarthritis Outcomes

A clinical trial is comparing the effects of two ozone concentrations (15 μg/mL and 25 μg/mL) in treating knee osteoarthritis.

ClinicalJune 2, 2026

Pilot Study on Geniculate Artery Embolization for Knee Osteoarthritis Initiated

A randomized pilot study is underway to evaluate the safety and efficacy of geniculate artery embolization in knee osteoarthritis.

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

Knee Osteoarthritis →

Osteoarthritis →

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.